Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer

Published:2023 Issue:8 Volume:64 Page:518
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Choi Hyungwook¹^ORCID,Ahn Sung Gwe²³^ORCID,Bae Soong Joon²³^ORCID,Kim Jee Hung³⁴^ORCID,Eun Na Lae⁵^ORCID,Lee Yangkyu¹³^ORCID,Nahm Ji Hae¹^ORCID,Jeong Joon²³^ORCID,Cha Yoon Jin¹³^ORCID

Affiliation:

1. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

3. Institute of Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Korea.

4. Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.

Funder

Yonsei University College of Medicine

Korea Health Industry Development Institute

Publisher

XMLink

Subject

General Medicine

Link

https://eymj.org/pdf/10.3349/ymj.2023.0090

Reference31 articles.

1. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

2. Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study

3. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis

4. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

5. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?;Breast Cancer Research;2024-03-11

2. Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms;Breast Cancer Research;2023-10-10

3. A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer;Annals of Surgical Treatment and Research;2023